< Back to Newsletter Archive

spacer
spacer

ON Twitter.COM/#BIF13icon_twtiter-sm

Overhead at #BIF13. 'Can U believe we're still standing at the podium and pitching after all these years? Where did we go wrong?" — @ldtimmerman

1 Retweet


Paul Hastings: we have potential to improve in industry w/ more data transparency abt drug failures. #BIF13 Not a popular line in pharma —@ldtimmerman


Orphan approach will be sustainable, says Esperion's Andreach, if "It's the right patient with the right drug for the right disease." #BIF13 —@BioWorld

5 Retweets


Not investing in NIH is silly, stupid and industry should be active, vocal and concerned about cuts. - Borisy #BIF13 — @Rrleuty_Biotech

4 Retweet


Primary care panel weighs in on ACA. Its impact will be "evolutionary rather than revolutionary," says NEA's Mathers. #BIF13 — @BioWorld

2 Retweets


Good stuff @IAmBiotech: here's a great summary from the plenary http://ow.ly/pEsZO — @IamBiotech

5 Retweets


Jan Lundberg: Bright people like to be around other bright people. You must have high standards. Give people freedom to operate, fail #BIF13 — @ldtimmerman

2 Retweets

spacer spacer spacer